{"issuance_frequency":"","notes_translated":{"fr":"Le Relevé des maladies transmissibles au Canada est une publication bilingue et libre d'accès revue par un comité de lecture portant sur la prévention et le contrôle des maladies infectieuses nouvelles et tenaces.","en":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. "},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"unknown","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"162ffd9c-d260-4312-90c4-0fb619d6f3ed","metadata_created":"2018-12-27T14:41:40.701798","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2018-12-27T14:41:40.701805","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2018-12-27","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Science de la mise en oeuvre","Infection émergente","Haemophilus influenzae de sérotype a","Possible vaccin","Développement d’un vaccin","Vaccination antigrippale","Vaccin contre l’hépatite B","Infections à Mycobacterium chimaera","Patients en phase post-opératoire exposés","Échangeurs thermiques","Évaluation","Surveillance","Infection tuberculeuse latente","Bactériémie chez les enfants en bas âge","Vaccins conjugués contre le pneumocoque","Évaluation du risque"],"en":["Implementation science","Emerging infection","Haemophilus influenzae serotype a","Potential vaccine","Developing a vaccine","Influenza Vaccine","Hepatitis B Vaccine","Mycobacterium chimaera infections","Post–operative patients exposed","Heater–cooler devices","Evaluation","Latent tuberculosis infection","Surveillance","Bacteremia","Children","Conjugated pneumococcal vaccines","Risk assessment"]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"RMTC : Volume 43-5, le 4 mai 2017 : Science de la mise en œuvre","en":"CCDR: Volume 43-5, May 4, 2017: Implementation science"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"162ffd9c-d260-4312-90c4-0fb619d6f3ed","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"1c99babd-430e-40dc-b54b-d32fa91f8aef","related_relationship":"","name_translated":{"fr":"RMTC : Volume 43-5, le 4 mai 2017 : Science de la mise en œuvre","en":"CCDR: Volume 43-5, May 4, 2017: Implementation science"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 43-5, May 4, 2017: Implementation science","language":["en"],"created":"2018-12-27T14:41:41.446289","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-5-may-4-2017.html","last_modified":null,"position":0,"revision_id":"e2743aa1-7cfb-4976-a9c5-367ba3876b26","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"162ffd9c-d260-4312-90c4-0fb619d6f3ed","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"7421ec46-1fe3-4d92-8401-31c8277a671e","related_relationship":"","name_translated":{"fr":"RMTC : Volume 43-5, le 4 mai 2017 : Science de la mise en œuvre","en":"CCDR: Volume 43-5, May 4, 2017: Implementation science"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 43-5, May 4, 2017: Implementation science","language":["fr"],"created":"2018-12-27T14:41:41.446297","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-5-4-mai-2017.html","last_modified":null,"position":1,"revision_id":"e2743aa1-7cfb-4976-a9c5-367ba3876b26","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"162ffd9c-d260-4312-90c4-0fb619d6f3ed","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"8d483acb-b3b7-4dbd-aa1e-931a37798986","related_relationship":"","name_translated":{"fr":"RMTC : Volume 43-5, le 4 mai 2017 : Science de la mise en œuvre","en":"CCDR: Volume 43-5, May 4, 2017: Implementation science"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 43-5, May 4, 2017: Implementation science","language":["en"],"created":"2018-12-27T14:41:41.446300","url":"https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/publicat/ccdr-rmtc/17vol43/dr-rm43-5/assets/pdf/17vol43_5-eng.pdf","last_modified":null,"position":2,"revision_id":"e2743aa1-7cfb-4976-a9c5-367ba3876b26","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"162ffd9c-d260-4312-90c4-0fb619d6f3ed","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"818d1c7d-7e5b-4deb-969a-203cd1b2936a","related_relationship":"","name_translated":{"fr":"RMTC : Volume 43-5, le 4 mai 2017 : Science de la mise en œuvre","en":"CCDR: Volume 43-5, May 4, 2017: Implementation science"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 43-5, May 4, 2017: Implementation science","language":["fr"],"created":"2018-12-27T14:41:41.446303","url":"https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/publicat/ccdr-rmtc/17vol43/dr-rm43-5/assets/pdf/17vol43_5-fra.pdf","last_modified":null,"position":3,"revision_id":"e2743aa1-7cfb-4976-a9c5-367ba3876b26","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"162ffd9c-d260-4312-90c4-0fb619d6f3ed","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"aaa28706-ecd0-4dbf-9582-7d0377d27afb","related_relationship":"","name_translated":{"fr":"L’infection émergente à Haemophilus influenzae de sérotype a et un possible vaccin : Science de la mise en œuvre","en":"The emerging Haemophilus influenzae serotype a infection and a potential vaccine: Implementation science in action"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"The emerging Haemophilus influenzae serotype a infection and a potential vaccine: Implementation science in action","language":["en"],"created":"2018-12-27T14:41:41.446305","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-5-may-4-2017/emerging-haemophilus-influenzae-serotype-infection-potential-vaccine.html","last_modified":null,"position":4,"revision_id":"e2743aa1-7cfb-4976-a9c5-367ba3876b26","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"162ffd9c-d260-4312-90c4-0fb619d6f3ed","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"85c8e4cc-3c7f-435c-9ac2-2c7c5a94a013","related_relationship":"","name_translated":{"fr":"L’infection émergente à Haemophilus influenzae de sérotype a et un possible vaccin : Science de la mise en œuvre","en":"The emerging Haemophilus influenzae serotype a infection and a potential vaccine: Implementation science in action"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"The emerging Haemophilus influenzae serotype a infection and a potential vaccine: Implementation science in action","language":["fr"],"created":"2018-12-27T14:41:41.446307","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-5-4-mai-2017/infection-emergente-haemophilus-influenzae-serotype-possible-vaccin.html","last_modified":null,"position":5,"revision_id":"e2743aa1-7cfb-4976-a9c5-367ba3876b26","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"162ffd9c-d260-4312-90c4-0fb619d6f3ed","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"f455dea5-affc-4284-9188-b1d1a5284b95","related_relationship":"","name_translated":{"fr":"Développement d’un vaccin contre Haemophilus influenzae de sérotype a","en":"Vaccine development for Haemophilus influenzae serotype a"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Vaccine development for Haemophilus influenzae serotype a","language":["en"],"created":"2018-12-27T14:41:41.446309","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-5-may-4-2017/developing-vaccine-haemophilus-influenzae-serotype-a.html","last_modified":null,"position":6,"revision_id":"e2743aa1-7cfb-4976-a9c5-367ba3876b26","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"162ffd9c-d260-4312-90c4-0fb619d6f3ed","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"064199a7-411b-4977-8d7f-432ec219d065","related_relationship":"","name_translated":{"fr":"Développement d’un vaccin contre Haemophilus influenzae de sérotype a","en":"Vaccine development for Haemophilus influenzae serotype a"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Vaccine development for Haemophilus influenzae serotype a","language":["fr"],"created":"2018-12-27T14:41:41.446312","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-5-4-mai-2017/developpement-vaccin-contre-haemophilus-influenzae-serotype-a.html","last_modified":null,"position":7,"revision_id":"e2743aa1-7cfb-4976-a9c5-367ba3876b26","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"162ffd9c-d260-4312-90c4-0fb619d6f3ed","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"160237d9-24e8-4d01-9e2e-c93afe4d144f","related_relationship":"","name_translated":{"fr":"Sommaire de la Déclaration du CCNI sur la vaccination antigrippale pour la saison 2017-2018","en":"Summary of the NACI Statement on Seasonal Influenza Vaccine for 2017–2018"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Summary of the NACI Statement on Seasonal Influenza Vaccine for 2017–2018","language":["en"],"created":"2018-12-27T14:41:41.446314","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-5-may-4-2017/summary-naci-statement-seasonal-influenza-vaccine-2017-2018.html","last_modified":null,"position":8,"revision_id":"e2743aa1-7cfb-4976-a9c5-367ba3876b26","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"162ffd9c-d260-4312-90c4-0fb619d6f3ed","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"d4fc4998-1c42-4a21-b651-ee092d38514c","related_relationship":"","name_translated":{"fr":"Sommaire de la Déclaration du CCNI sur la vaccination antigrippale pour la saison 2017-2018","en":"Summary of the NACI Statement on Seasonal Influenza Vaccine for 2017–2018"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Summary of the NACI Statement on Seasonal Influenza Vaccine for 2017–2018","language":["fr"],"created":"2018-12-27T14:41:41.446316","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-5-4-mai-2017/sommaire-declaration-ccni-vaccination-antigrippale-saison-2017-2018.html","last_modified":null,"position":9,"revision_id":"e2743aa1-7cfb-4976-a9c5-367ba3876b26","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"162ffd9c-d260-4312-90c4-0fb619d6f3ed","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"783182f4-1a80-4d77-9fac-c0b379311ea1","related_relationship":"","name_translated":{"fr":"Infections à Mycobacterium chimaera chez les patients en phase post-opératoire exposés à des échangeurs thermiques : Un aperçu","en":"Mycobacterium chimaera infections in post–operative patients exposed toheater–cooler devices: An overview"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Mycobacterium chimaera infections in post–operative patients exposed toheater–cooler devices: An overview","language":["en"],"created":"2018-12-27T14:41:41.446318","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-5-may-4-2017/mycobacterium-chimaera-infections-post-operative-patients-exposed-heater-cooler-devices.html","last_modified":null,"position":10,"revision_id":"e2743aa1-7cfb-4976-a9c5-367ba3876b26","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"162ffd9c-d260-4312-90c4-0fb619d6f3ed","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"e32b6153-1887-4532-9965-80762a2a7361","related_relationship":"","name_translated":{"fr":"Infections à Mycobacterium chimaera chez les patients en phase post-opératoire exposés à des échangeurs thermiques : Un aperçu","en":"Mycobacterium chimaera infections in post–operative patients exposed toheater–cooler devices: An overview"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Mycobacterium chimaera infections in post–operative patients exposed toheater–cooler devices: An overview","language":["fr"],"created":"2018-12-27T14:41:41.446321","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-5-4-mai-2017/infections-mycobacterium-chimaera-patients-phase-post-operatoire-exposes-echangeurs-thermiques.html","last_modified":null,"position":11,"revision_id":"e2743aa1-7cfb-4976-a9c5-367ba3876b26","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"162ffd9c-d260-4312-90c4-0fb619d6f3ed","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"4279d4f5-29cc-4b4a-b041-ff72bf2823f7","related_relationship":"","name_translated":{"fr":"Évaluation de la surveillance de l'infection tuberculeuse latente dans la région de Peel, en Ontario, 2010 à 2014","en":"Evaluation of latent tuberculosis infection surveillance in Peel region, Ontario, 2010–2014"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Evaluation of latent tuberculosis infection surveillance in Peel region, Ontario, 2010–2014","language":["en"],"created":"2018-12-27T14:41:41.446323","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-5-may-4-2017/evaluation-latent-tuberculosis-infection-surveillance-peel-region-ontario-2010-2014.html","last_modified":null,"position":12,"revision_id":"e2743aa1-7cfb-4976-a9c5-367ba3876b26","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"162ffd9c-d260-4312-90c4-0fb619d6f3ed","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"4778a40a-e3fb-4e9a-8802-8229daac1c72","related_relationship":"","name_translated":{"fr":"Évaluation de la surveillance de l'infection tuberculeuse latente dans la région de Peel, en Ontario, 2010 à 2014","en":"Evaluation of latent tuberculosis infection surveillance in Peel region, Ontario, 2010–2014"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Evaluation of latent tuberculosis infection surveillance in Peel region, Ontario, 2010–2014","language":["fr"],"created":"2018-12-27T14:41:41.446325","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-5-4-mai-2017/evaluation-surveillance-infection-tuberculeuse-latente-region-peel-ontario-2010-2014.html","last_modified":null,"position":13,"revision_id":"e2743aa1-7cfb-4976-a9c5-367ba3876b26","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"162ffd9c-d260-4312-90c4-0fb619d6f3ed","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"adea7fac-2dcd-413c-ab54-1764dcb1649a","related_relationship":"","name_translated":{"fr":"La bactériémie chez les enfants en bas âge après l’introduction de vaccins conjugués contre le pneumocoque","en":"Bacteremia in children following introduction of conjugated pneumococcal vaccines"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Bacteremia in children following introduction of conjugated pneumococcal vaccines","language":["en"],"created":"2018-12-27T14:41:41.446327","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-5-may-4-2017/news.html#a1","last_modified":null,"position":14,"revision_id":"e2743aa1-7cfb-4976-a9c5-367ba3876b26","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"162ffd9c-d260-4312-90c4-0fb619d6f3ed","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"7acfd9d5-2bf2-4229-a720-d1ba239d7a8c","related_relationship":"","name_translated":{"fr":"La bactériémie chez les enfants en bas âge après l’introduction de vaccins conjugués contre le pneumocoque","en":"Bacteremia in children following introduction of conjugated pneumococcal vaccines"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Bacteremia in children following introduction of conjugated pneumococcal vaccines","language":["fr"],"created":"2018-12-27T14:41:41.446354","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-5-4-mai-2017/actualites.html#a1","last_modified":null,"position":15,"revision_id":"e2743aa1-7cfb-4976-a9c5-367ba3876b26","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"162ffd9c-d260-4312-90c4-0fb619d6f3ed","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"9a3c781d-e1c6-4ba2-b38b-f1a9a00ac25b","related_relationship":"","name_translated":{"fr":"L’évaluation du risque pour Mycobacterium chimaera","en":"Risk assessment for Mycobacterium chimaera"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Risk assessment for Mycobacterium chimaera","language":["en"],"created":"2018-12-27T14:41:41.446356","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-5-may-4-2017/news.html#a2","last_modified":null,"position":16,"revision_id":"e2743aa1-7cfb-4976-a9c5-367ba3876b26","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"162ffd9c-d260-4312-90c4-0fb619d6f3ed","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"016fd7ba-43ed-4a62-8467-895ff12c0600","related_relationship":"","name_translated":{"fr":"L’évaluation du risque pour Mycobacterium chimaera","en":"Risk assessment for Mycobacterium chimaera"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Risk assessment for Mycobacterium chimaera","language":["fr"],"created":"2018-12-27T14:41:41.446359","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-5-4-mai-2017/actualites.html#a2","last_modified":null,"position":17,"revision_id":"e2743aa1-7cfb-4976-a9c5-367ba3876b26","resource_type":"website"}],"place_of_publication":[],"num_resources":18,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2017-05-04 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"162ffd9c-d260-4312-90c4-0fb619d6f3ed","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. ","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"CCDR: Volume 43-5, May 4, 2017: Implementation science","revision_id":"e2743aa1-7cfb-4976-a9c5-367ba3876b26"}